• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于改善 NVP-BEZ235 在 T 细胞淋巴瘤中跨膜转运的细胞穿透性碳酸钙纳米晶体

Cell-Penetrating CaCO₃ Nanocrystals for Improved Transport of NVP-BEZ235 across Membrane Barrier in T-Cell Lymphoma.

作者信息

Vergaro Viviana, Civallero Monica, Citti Cinzia, Cosenza Maria, Baldassarre Francesca, Cannazza Giuseppe, Pozzi Samantha, Sacchi Stefano, Fanizzi Francesco Paolo, Ciccarella Giuseppe

机构信息

Dipartimento di Scienze e Tecnologie Biologiche e Ambientali, Università del Salento & UdR INSTM di Lecce, Campus Universitario, Via Monteroni, 73100 Lecce, Italy.

Dipartimento di Medicina Diagnostica, Clinica e di Sanità Pubblica, Università di Modena & Reggio Emilia, via Campi 287, 41125 Modena, Italy.

出版信息

Cancers (Basel). 2018 Jan 25;10(2):31. doi: 10.3390/cancers10020031.

DOI:10.3390/cancers10020031
PMID:29370086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5836063/
Abstract

Owing to their nano-sized porous structure, CaCO₃ nanocrystals (CaCO₃NCs) hold the promise to be utilized as desired materials for encapsulating molecules which demonstrate wide promise in drug delivery. We evaluate the possibility to encapsulate and release NVP-BEZ235, a novel and potent dual PI3K/mTOR inhibitor that is currently in phase I/II clinical trials for advanced solid tumors, from the CaCO₃NCs. Its chemical nature shows some intrinsic limitations which induce to administer high doses leading to toxicity; to overcome these problems, here we proposed a strategy to enhance its intracellular penetration and its biological activity. Pristine CaCO₃ NCs biocompatibility, cell interactions and internalization in in vitro experiments on T-cell lymphoma line, were studied. Confocal microscopy was used to monitor NCs-cell interactions and cellular uptake. We have further investigated the interaction nature and release mechanism of drug loaded/released within/from the NCs using an alternative approach based on liquid chromatography coupled to mass spectrometry. Our approach provides a good loading efficiency, therefore this drug delivery system was validated for biological activity in T-cell lymphoma: the anti-proliferative test and western blot results are very interesting because the proposed nano-formulation has an efficiency higher than free drug at the same nominal concentration.

摘要

由于其纳米级多孔结构,碳酸钙纳米晶体(CaCO₃NCs)有望成为用于封装分子的理想材料,这些分子在药物递送方面具有广阔前景。我们评估了从CaCO₃NCs中封装和释放NVP-BEZ235的可能性,NVP-BEZ235是一种新型且有效的双PI3K/mTOR抑制剂,目前正处于针对晚期实体瘤的I/II期临床试验阶段。其化学性质存在一些内在局限性,导致需要高剂量给药从而引发毒性;为克服这些问题,我们在此提出一种策略,以增强其细胞内穿透能力及其生物活性。研究了原始CaCO₃ NCs在T细胞淋巴瘤细胞系体外实验中的生物相容性、细胞相互作用和内化情况。共聚焦显微镜用于监测NCs与细胞的相互作用以及细胞摄取。我们还使用基于液相色谱-质谱联用的另一种方法,进一步研究了药物在NCs内/从NCs中加载/释放的相互作用性质和释放机制。我们的方法具有良好的负载效率,因此该药物递送系统在T细胞淋巴瘤中的生物活性得到了验证:抗增殖试验和蛋白质印迹结果非常有趣,因为在相同标称浓度下,所提出的纳米制剂的效率高于游离药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8827/5836063/99645108be0f/cancers-10-00031-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8827/5836063/fdf9f65ca320/cancers-10-00031-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8827/5836063/aad9d4b30d98/cancers-10-00031-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8827/5836063/a6a65a934d5b/cancers-10-00031-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8827/5836063/94ce0d26e8d7/cancers-10-00031-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8827/5836063/bb989a1971b1/cancers-10-00031-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8827/5836063/99645108be0f/cancers-10-00031-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8827/5836063/fdf9f65ca320/cancers-10-00031-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8827/5836063/aad9d4b30d98/cancers-10-00031-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8827/5836063/a6a65a934d5b/cancers-10-00031-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8827/5836063/94ce0d26e8d7/cancers-10-00031-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8827/5836063/bb989a1971b1/cancers-10-00031-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8827/5836063/99645108be0f/cancers-10-00031-g006.jpg

相似文献

1
Cell-Penetrating CaCO₃ Nanocrystals for Improved Transport of NVP-BEZ235 across Membrane Barrier in T-Cell Lymphoma.用于改善 NVP-BEZ235 在 T 细胞淋巴瘤中跨膜转运的细胞穿透性碳酸钙纳米晶体
Cancers (Basel). 2018 Jan 25;10(2):31. doi: 10.3390/cancers10020031.
2
The PI3K/mTOR dual inhibitor BEZ235 nanoparticles improve radiosensitization of hepatoma cells through apoptosis and regulation DNA repair pathway.PI3K/mTOR双重抑制剂BEZ235纳米颗粒通过诱导凋亡和调节DNA修复途径提高肝癌细胞的放射敏感性。
Nanoscale Res Lett. 2020 Mar 26;15(1):63. doi: 10.1186/s11671-020-3289-z.
3
Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia.新型双重磷脂酰肌醇 3-激酶/哺乳动物雷帕霉素靶蛋白抑制剂 NVP-BEZ235 对 T 细胞急性淋巴细胞白血病的作用。
Cancer Res. 2010 Oct 15;70(20):8097-107. doi: 10.1158/0008-5472.CAN-10-1814. Epub 2010 Sep 28.
4
NVP-BEZ235 alone and in combination in mantle cell lymphoma: an effective therapeutic strategy.NVP-BEZ235 单药及联合治疗套细胞淋巴瘤:一种有效的治疗策略。
Expert Opin Investig Drugs. 2012 Nov;21(11):1597-606. doi: 10.1517/13543784.2012.719871. Epub 2012 Aug 25.
5
The dual PI3K/mTOR inhibitor NVP-BEZ235 is a potent inhibitor of ATM- and DNA-PKCs-mediated DNA damage responses.双重 PI3K/mTOR 抑制剂 NVP-BEZ235 是一种强效的 ATM 和 DNA-PKCs 介导的 DNA 损伤反应抑制剂。
Neoplasia. 2012 Jan;14(1):34-43. doi: 10.1593/neo.111512.
6
Autophagy inhibition enhances colorectal cancer apoptosis induced by dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.自噬抑制增强了双磷脂酰肌醇3激酶/雷帕霉素哺乳动物靶标抑制剂NVP-BEZ235诱导的结直肠癌凋亡。
Oncol Lett. 2016 Jul;12(1):102-106. doi: 10.3892/ol.2016.4590. Epub 2016 May 17.
7
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.双重PI3K和mTOR抑制剂NVP-BEZ235联合甲磺酸伊马替尼对慢性粒细胞白血病细胞系的疗效。
Drug Des Devel Ther. 2017 Apr 3;11:1115-1126. doi: 10.2147/DDDT.S132092. eCollection 2017.
8
Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models.对PI3K/AKT/mTOR(NVP-BEZ235)和Ras/Raf/MEK(AZD6244)通路的双重阻断可协同抑制原发性子宫内膜样子宫内膜癌培养物的生长,而NVP-BEZ235可减少相应异种移植模型中的肿瘤生长。
Gynecol Oncol. 2015 Jul;138(1):165-73. doi: 10.1016/j.ygyno.2015.04.028. Epub 2015 Apr 28.
9
Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 has a therapeutic potential and sensitizes cisplatin in nasopharyngeal carcinoma.双重磷酸肌醇 3-激酶/雷帕霉素哺乳动物靶蛋白抑制剂 NVP-BEZ235 具有治疗潜力,并增敏鼻咽癌中的顺铂。
PLoS One. 2013;8(3):e59879. doi: 10.1371/journal.pone.0059879. Epub 2013 Mar 22.
10
Dual inhibitor of phosphoinositide 3-kinase/mammalian target of rapamycin NVP-BEZ235 effectively inhibits cisplatin-resistant urothelial cancer cell growth through autophagic flux.磷酸肌醇 3-激酶/雷帕霉素哺乳动物靶点双重抑制剂 NVP-BEZ235 通过自噬流有效抑制顺铂耐药性膀胱癌细胞生长。
Toxicol Lett. 2013 Jul 18;220(3):267-76. doi: 10.1016/j.toxlet.2013.04.021. Epub 2013 May 4.

引用本文的文献

1
Counteracting Immunosenescence-Which Therapeutic Strategies Are Promising?对抗免疫衰老——哪些治疗策略有前景?
Biomolecules. 2023 Jul 6;13(7):1085. doi: 10.3390/biom13071085.
2
Enhanced Bioactivity of Pomegranate Peel Extract following Controlled Release from CaCO Nanocrystals.碳酸钙纳米晶体控释后石榴皮提取物的生物活性增强
Bioinorg Chem Appl. 2022 Feb 12;2022:6341298. doi: 10.1155/2022/6341298. eCollection 2022.
3
Is There a Role for Dual PI3K/mTOR Inhibitors for Patients Affected with Lymphoma?双重 PI3K/mTOR 抑制剂在淋巴瘤患者中的作用如何?

本文引用的文献

1
Composite cyclodextrin-calcium carbonate porous microparticles and modified multilayer capsules: novel carriers for encapsulation of hydrophobic drugs.复合环糊精 - 碳酸钙多孔微粒及改性多层胶囊:用于包封疏水性药物的新型载体。
J Mater Chem B. 2013 Jul 7;1(25):3175-3184. doi: 10.1039/c3tb20192a. Epub 2013 May 23.
2
CaCO nanoparticles as an ultra-sensitive tumor-pH-responsive nanoplatform enabling real-time drug release monitoring and cancer combination therapy.碳酸钙纳米颗粒作为一种超灵敏的肿瘤 pH 响应型纳米平台,可实现实时药物释放监测和癌症联合治疗。
Biomaterials. 2016 Dec;110:60-70. doi: 10.1016/j.biomaterials.2016.09.025. Epub 2016 Sep 29.
3
Int J Mol Sci. 2020 Feb 5;21(3):1060. doi: 10.3390/ijms21031060.
4
CaCO as an Environmentally Friendly Renewable Material for Drug Delivery Systems: Uptake of HSA-CaCO Nanocrystals Conjugates in Cancer Cell Lines.碳酸钙作为药物递送系统的一种环境友好型可再生材料:人血清白蛋白 - 碳酸钙纳米晶体缀合物在癌细胞系中的摄取情况
Materials (Basel). 2019 May 7;12(9):1481. doi: 10.3390/ma12091481.
Monodispersed calcium carbonate nanoparticles modulate local pH and inhibit tumor growth in vivo.
单分散碳酸钙纳米颗粒调节局部 pH 值并抑制体内肿瘤生长。
Nanoscale. 2016 Jul 7;8(25):12639-47. doi: 10.1039/c5nr06162h. Epub 2016 Jan 8.
4
Neuroendocrine tumors resistant to mammalian target of rapamycin inhibitors: A difficult conversion from biology to the clinic.对雷帕霉素哺乳动物靶点抑制剂耐药的神经内分泌肿瘤:从生物学向临床转化的难题。
World J Clin Oncol. 2015 Dec 10;6(6):194-7. doi: 10.5306/wjco.v6.i6.194.
5
Synthesis of biocompatible polymeric nano-capsules based on calcium carbonate: A potential cisplatin delivery system.基于碳酸钙的生物相容性聚合物纳米胶囊的合成:一种潜在的顺铂递送系统。
J Inorg Biochem. 2015 Dec;153:284-292. doi: 10.1016/j.jinorgbio.2015.10.014. Epub 2015 Nov 1.
6
Activity of BKM120 and BEZ235 against Lymphoma Cells.BKM120和BEZ235对淋巴瘤细胞的活性。
Biomed Res Int. 2015;2015:870918. doi: 10.1155/2015/870918. Epub 2015 Oct 18.
7
Developing Exposure/Response Models for Anticancer Drug Treatment: Special Considerations.开发抗癌药物治疗的暴露/反应模型:特殊考量
CPT Pharmacometrics Syst Pharmacol. 2015 Jan;4(1):e00016. doi: 10.1002/psp4.16. Epub 2015 Jan 21.
8
Calcium carbonate nanoparticles as cancer drug delivery system.碳酸钙纳米颗粒作为癌症药物输送系统。
Expert Opin Drug Deliv. 2015;12(10):1649-60. doi: 10.1517/17425247.2015.1049530. Epub 2015 May 25.
9
A preloaded amorphous calcium carbonate/doxorubicin@silica nanoreactor for pH-responsive delivery of an anticancer drug.载药无定形碳酸钙/阿霉素@二氧化硅纳米反应器用于 pH 响应型抗癌药物递送。
Angew Chem Int Ed Engl. 2015 Jan 12;54(3):919-22. doi: 10.1002/anie.201408510. Epub 2014 Nov 24.
10
Biocompatibility of bio based calcium carbonate nanocrystals aragonite polymorph on NIH 3T3 fibroblast cell line.基于生物的碳酸钙纳米晶体文石多晶型物对NIH 3T3成纤维细胞系的生物相容性
Afr J Tradit Complement Altern Med. 2014 Jun 4;11(4):31-8. doi: 10.4314/ajtcam.v11i4.5. eCollection 2014.